sekio
Bluelight Crew
Lundbeck files novel antidepressant vortioxetine in EU
PMLive
http://www.pmlive.com/pharma_news/lundbeck_files_novel_antidepressant_vortioxetine_in_eu_426534
http://en.wikipedia.org/wiki/Vortioxetine
Yeah yeah, patent grab, et cetera. And that drug structure does look kinda nasty, I mean, a xylene thiocresol type thing? Count me right out. (Obviously it's been shown it doesn't come popping off, since it's effective for depression with "fewer side effects" than the standards & people aint dying, but...)
The implication of less sexual disruption and more "targeted" activity makes me feel kinda warm and fuzzy. Less of a reason to avoid medication for those who need it but won't use it for fear of permanent sexual dysfunction. (please let's not turn this thread into an "I took Lexapro and now can't get a boner")
Related drugs are apparently triple reuptake inhibitors so maybe there's a way to modify it to make homemade super coke. Haha, not.
PMLive
Lundbeck has submitted its antidepressant drug candidate vortioxetine in Europe, raising hopes that it could become the first novel drug treatment for depression to reach the market since 2007.
Vortioxetine (formerly Lu AA21004) is described as a multimodal antidepressant, working as a serotonin 5-HT3 and 5-HT7 receptor antagonist, and 5-HT1b receptor partial agonist, and 5-HT1a receptor agonist and an inhibitor of the serotonin transporter SERT.
The drug is a critical pipeline product for Lundbeck as it tries to find replacements for big-selling antidepressant Lexapro/Cipralex (escitalopram) as well as other products that stand to lose patent protection over the next few years, putting around $1.6bn in revenues at risk of generic competition.
http://www.pmlive.com/pharma_news/lundbeck_files_novel_antidepressant_vortioxetine_in_eu_426534
http://en.wikipedia.org/wiki/Vortioxetine
Yeah yeah, patent grab, et cetera. And that drug structure does look kinda nasty, I mean, a xylene thiocresol type thing? Count me right out. (Obviously it's been shown it doesn't come popping off, since it's effective for depression with "fewer side effects" than the standards & people aint dying, but...)
The implication of less sexual disruption and more "targeted" activity makes me feel kinda warm and fuzzy. Less of a reason to avoid medication for those who need it but won't use it for fear of permanent sexual dysfunction. (please let's not turn this thread into an "I took Lexapro and now can't get a boner")
Related drugs are apparently triple reuptake inhibitors so maybe there's a way to modify it to make homemade super coke. Haha, not.

